AMERICAN SHARED HOSPITAL SERVICES (AMS) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 16.22M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 52.49M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $16.22M | (m) | (m) | (m) | $52.49M | (m) |
| 2026-03-31 | (m) | (m) | $16.84M | (m) | (m) | (m) | $54.73M | (m) |
| 2025-12-31 | (m) | (m) | $17.29M | $0.00 | (m) | (m) | $55.48M | (m) |
| 2025-09-30 | (m) | (m) | $9.55M | $8.63M | (m) | (m) | $59.63M | (m) |
| 2025-06-30 | (m) | (m) | $9.87M | $9.22M | (m) | (m) | $63.49M | (m) |
| 2025-03-31 | (m) | (m) | $3.13M | $16.80M | (m) | (m) | $63.31M | (m) |
| 2024-12-31 | (m) | (m) | $2.84M | $17.34M | (m) | (m) | $60.20M | (m) |
| 2024-09-30 | (m) | (m) | $3.56M | $10.82M | (m) | (m) | $63.27M | (m) |
| 2024-06-30 | (m) | (m) | $3.03M | $12.05M | (m) | (m) | $60.83M | (m) |
| 2024-03-31 | (m) | (m) | $2.71M | $12.89M | (m) | (m) | $50.12M | (m) |
| 2023-12-31 | (m) | (m) | $2.08M | $11.04M | (m) | (m) | $48.16M | (m) |
| 2023-09-30 | (m) | (m) | $1.46M | $10.45M | (m) | (m) | $47.36M | (m) |
| 2023-06-30 | (m) | (m) | $1.26M | $11.08M | (m) | (m) | $44.46M | (m) |
| 2023-03-31 | (m) | (m) | $1.26M | $11.49M | (m) | (m) | $43.55M | (m) |
| 2022-12-31 | (m) | (m) | $1.26M | $12.21M | (m) | (m) | $43.96M | (m) |
| 2022-09-30 | (m) | (m) | $1.26M | $12.62M | (m) | (m) | $43.41M | (m) |
| 2022-06-30 | (m) | (m) | $1.64M | $13.50M | (m) | (m) | $44.52M | (m) |
| 2022-03-31 | (m) | (m) | $1.64M | $13.72M | (m) | (m) | $44.26M | (m) |
| 2021-12-31 | (m) | (m) | $1.08M | $14.32M | (m) | (m) | $45.43M | (m) |
| 2021-09-30 | (m) | (m) | $1.08M | $14.73M | (m) | (m) | $44.15M | (m) |
| 2021-06-30 | (m) | (m) | $893.00K | $15.15M | (m) | (m) | $44.98M | (m) |
| 2021-03-31 | (m) | (m) | $782.00K | $11.82M | (m) | (m) | $44.05M | (m) |
| 2020-12-31 | (m) | (m) | $1.16M | $3.44M | (m) | (m) | $43.65M | (m) |
| 2020-09-30 | (m) | (m) | $1.22M | $3.72M | (m) | (m) | $52.34M | (m) |
| 2020-06-30 | (m) | (m) | $1.25M | $4.04M | (m) | (m) | $53.88M | (m) |
| 2020-03-31 | (m) | (m) | $1.45M | $2.92M | (m) | (m) | $53.19M | (m) |
| 2019-12-31 | (m) | (m) | $1.53M | $1.95M | (m) | (m) | $53.78M | (m) |
| 2019-09-30 | (m) | (m) | $1.67M | $2.23M | (m) | (m) | $55.26M | (m) |
| 2019-06-30 | (m) | (m) | $1.98M | $2.50M | (m) | (m) | $55.57M | (m) |
| 2019-03-31 | (m) | (m) | $2.04M | $2.89M | (m) | (m) | $56.86M | (m) |
| 2018-12-31 | (m) | (m) | $2.12M | $3.33M | (m) | (m) | $57.50M | (m) |
| 2018-09-30 | (m) | (m) | $2.07M | $2.12M | (m) | (m) | $56.47M | (m) |
| 2018-06-30 | (m) | (m) | $2.17M | $2.62M | (m) | (m) | $58.07M | (m) |
| 2018-03-31 | (m) | (m) | $2.46M | $3.11M | (m) | (m) | $58.03M | (m) |
| 2017-12-31 | (m) | (m) | $2.46M | $3.60M | (m) | (m) | $58.18M | (m) |
| 2017-09-30 | (m) | (m) | $2.50M | $4.22M | (m) | (m) | $59.98M | (m) |
| 2017-06-30 | (m) | (m) | $2.35M | (m) | (m) | (m) | $58.99M | (m) |
| 2017-03-31 | (m) | (m) | $2.21M | (m) | (m) | (m) | $60.43M | (m) |
| 2016-12-31 | (m) | (m) | $2.21M | (m) | (m) | (m) | $60.60M | (m) |
| 2016-09-30 | (m) | (m) | $1.86M | (m) | (m) | (m) | $59.85M | (m) |
| 2016-06-30 | (m) | (m) | $2.60M | (m) | (m) | (m) | $59.30M | (m) |
| 2016-03-31 | (m) | (m) | $2.64M | (m) | (m) | (m) | $60.09M | (m) |
| 2015-12-31 | (m) | (m) | $2.67M | (m) | (m) | (m) | $54.11M | (m) |
| 2015-09-30 | (m) | (m) | $2.78M | (m) | (m) | (m) | $55.89M | (m) |
| 2015-06-30 | (m) | (m) | $2.85M | (m) | (m) | (m) | $56.93M | (m) |
| 2015-03-31 | (m) | (m) | $2.02M | (m) | (m) | (m) | $58.95M | (m) |
| 2014-12-31 | (m) | (m) | $2.00M | (m) | (m) | (m) | $67.53M | (m) |
| 2014-09-30 | (m) | (m) | $2.06M | (m) | (m) | (m) | $63.52M | (m) |
| 2014-06-30 | (m) | (m) | $2.54M | (m) | (m) | (m) | $65.26M | (m) |
| 2014-03-31 | (m) | (m) | $4.58M | (m) | (m) | (m) | $69.78M | (m) |
| 2013-12-31 | (m) | (m) | $4.80M | (m) | (m) | (m) | $71.74M | (m) |
| 2013-09-30 | (m) | (m) | $4.38M | (m) | (m) | (m) | $72.15M | (m) |
| 2013-06-30 | (m) | (m) | $4.60M | (m) | (m) | (m) | $73.83M | (m) |
| 2013-03-31 | (m) | (m) | $4.16M | (m) | (m) | (m) | $72.15M | (m) |
| 2012-12-31 | (m) | (m) | $3.93M | (m) | (m) | (m) | $73.32M | (m) |
| 2012-09-30 | (m) | (m) | $4.57M | (m) | (m) | (m) | $73.42M | (m) |
| 2012-06-30 | (m) | (m) | $4.49M | (m) | (m) | (m) | $74.36M | (m) |
| 2012-03-31 | (m) | (m) | $3.64M | (m) | (m) | (m) | $76.07M | (m) |
| 2011-12-31 | (m) | (m) | $3.94M | (m) | (m) | (m) | $74.53M | (m) |
| 2011-09-30 | (m) | (m) | $3.12M | (m) | (m) | (m) | $66.84M | (m) |
| 2011-06-30 | (m) | (m) | $3.53M | (m) | (m) | (m) | $68.11M | (m) |
| 2010-12-31 | (m) | (m) | $3.47M | (m) | (m) | (m) | $65.34M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |